Some reports are in PDF format and need Adobe Acrobat Reader for viewing properly. It can be downloaded free from Adobe website.

  1. Vaidya PR, Jain AB, Thakur SS. Urinary Fistula: Study of 40 cases of vesico-vaginal fistula over a period of ten years at Nair Hospital, analyzing etiology, management and comparing the results. Journal of Post-Graduate Medicine, India 21:68-74, 1975 PubMed

  2. McMaster P, Jurewig WA, Kirby RM, Jain AB, Augrisani L. The hazards of pancreatic transplantation complications of immunosuppressive therapy, Transplant Proc 43(4 Suppl 3):58-61, 1986.

  3. Jain AB, Augrisani L, McMaster P. Staghorn calculus in renal allograft. Transplant Proc 18(4):959-962, 1986. PubMed

  4. Augrisani L, Jurewicz WA, Clements 0G, Kirby RM, Jain AB, Elias E, McMaster P. Liver transplantation for liver cancers. Transplant Proc 18(5):1218-1219, 1986.

  5. Brown P, Buckles JAC, Jain AB, McMaster P. Successful cadaveric renal transplant from a donor who died of cyanide poisoning. Brit Med J 294:1325, 1987 PubMed / PDF

  6. Jain AB, Lee M, Bewar P, Chan SY. Primary angio-sarcoma of the spleen: A diagnosis to consider. Eur J Surg Oncol 14:341-343, 1988. PubMed / PDF

  7. Jain AB, Buckles JAC, Adu D, Michael J, Mackintosh P, McMaster P. Long-term results of cyclosporine renal transplantation from a single center. Transplant Proc 20(3 Suppl 3):82-85, 1988. PubMed / PDF

  8. Jain AB, Elias E, Gunson BK, Buckles JAC, McDowell B, Millis AH, McMaster P. Is elimination of cyclosporine in bile dependent on liver graft function and biliary drainage? Transplant Proc 20(2):516-522, 1988. PubMed

  9. Jain AB, Young CH. Anterior transperitoneal approach to the upper urinary tract with one stage bilateral procedure. Brit J Urol 63:239-242, 1989. PubMed / PDF

  10. Starzl TE, Todo S, Fung JJ, Demetris AJ, Venkataramanan R, Jain AB. FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000-1004, 1989. PubMed / PDF

  11. Fung JJ, Todo S, Jain AB, McCauley J, Alessiani M, Scotti C, Starzl TE. Conversion of liver allograft recipients with cyclosporine-related complications from cyclosporine to FK 506, Transplant Proc 22(1):6-12, 1990. PubMed / PDF

  12. Todo S, Fung JJ, Demetris AJ, Jain AB, Venkataramanan R, Starzl TE. Early trials with FK 506 as primary treatment in liver transplantation, Transplant Proc 22(2):13-16, 1990. PubMed

  13. McCauley J, Fung JJ, Jain AB, Todo S, Starzl TE. The effects of FK 506 upon renal function after liver transplantation, Transplant Proc 22(1):17-20, 1990. PubMed / PDF

  14. Jain AB, Fung JJ, Venkataramanan R, Todo S, Alessiani M, Starzl TE. FK 506 dosage in human organ transplantation, Transplant Proc 22(1):23-24, 1990. PubMed / PDF

  15. Shapiro R, Fung JJ, Jain AB, Parks P, Todo S, Starzl TE. The side effects of FK 506 in humans, Transplant Proc 22(1):35-36, 1990. PubMed / PDF

  16. Van Thiel DH, Iqbal M, Jain AB, Fung JJ, Todo S, Starzl TE. Gastrointestinal and metabolic problems associated with immunosuppression with either cyclosporine or FK 506 in liver transplantation. Transplant Proc 22(1):37-40, 1990. PubMed / PDF

  17. Alessiani M, Kusne S, Martin FM, Fung JJ, Jain AB, Todo S, Simmons R, Starzl TE. Infections under FK 506 immunosuppression: Preliminary results with primary therapy. Transplant Proc 22(1):44-46, 1990. PubMed / PDF

  18. Staschak S, Wagner S, Block G, Van Thiel DH, Jain AB, Fung JJ, Todo S, Starzl TE.Cost comparison of liver transplantation with FK50 or Cyclosporine as the primary immunosuppressive agent, Transplant Proc 22:47-49, 1990. PubMed / PDF

  19. Venkataramanan R, Jain AB, Cadoff E, Fung JJ, Warty V, Krajack A, Imventarza O, Todo S, Fung JJ, Starzl, TE. Pharmacokinetics of FK 506 Preclinical and Clinical Studies, Transplant Proc 22(1):52-56, 1990. PubMed / PDF

  20. Jain AB, Venkataramanan R, Cadoff E, Fung JJ, Todo S, Krajack A, Starzl TE. Effect of hepatic dysfunction and T-tube clamping on FK 506 pharmacokinetics and trough concentrations, Transplant Proc 22(1):57-59, 1990. PubMed / PDF

  21. Zeevi A, Eiras G, Burckart G, Jain AB, Krajack A, Venkataramanan R, Todo S, Fung JJ, Starzl TE, Duquesnoy RJ. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression, Transplant Proc 22(1):60-63, 1990. PubMed / PDF

  22. Burckart GJ, Jain AB, Diven W, Venkataramanan R, Starzl TE. Cyclosporine measurement by FPIA, PcRIA, and HPLC following liver transplantation, Transplant Proc 22:1319-1322, 1990. PubMed / PDF

  23. Gunson BK, Jones SR, Buckles JAC, Jain AB, McMaster P. Liver Transplantation in Birmingham: use of Cyclosporine–Clinical correlation with drug monitoring. Transplant Proc 22:1312-1318, 1990. PubMed

  24. Todo S, Fung JJ, Starzl TE, Tzakis A, Demetris AJ, Kormos R, Jain AB, Alessiani M, Takaya S, Shapiro R. Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 212(3):295-307, 1990. PubMed / PDF

  25. Mieles, L., S. Todo, Fung, J. J. , Jain AB., Furukawa, H., Susuki, M., Starzl, and T. E.(1990). “The side effects of FK 506 in humans.” Transplant Proc 22(1)” 41-3

  26. Starzl TE, Fung JJ, Jordan M, Shapiro R, Tzakis A, McCauley J, Johnston J, Iwaki Y, Jain AB, Alessiani M, Todo S. Kidney transplantation under FK 506. JAMA 264:63-67, 1990 PubMed / PDF

  27. Fung JJ, Abu-Elmagd K, Alessiani M, Armitage J, Bloom E, Bronsther O, Casavilla A, Demetris AJ, Gordon R, Hakala T, Imventarza O, Jaffe R, Jain AB, Jordan M, Kormos R, Martin M, McCauley J, Przepiorka D, Scantlebury V, Selby R, Shapiro R, Starzl TE, Staschak S, Strieber A, Todo S, Tzakis A, Van Thiel DH: Overview of FK 506 in transplantation. In: Terasaki PI, ed. Clinical Transplants 1990 Los Angeles, CA, UCLA Tissue Typing Laboratory, 1991:115-121 PubMed / PDF

  28. Abu-Elmagd K, Fung JJ, Alessiani M, Jain AB, Venkataramanan R, Warty VS, Takaya S, Todo S, Shannon WD, Starzl TE. The effect of graft function on FK 506 plasma levels, dosages, and renal function, with particular reference to the liver, Transplantation 52(1):71-77, 1991. PubMed / PDF

  29. Jain AB, Fung JJ, Todo S, Alessiani M, Takaya S, Abu-Elmagd K, Tzakis AG, Starzl TE. Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506, Transplant Proc 23(1 Pt. 2):928-930, 1991. PubMed / PDF

  30. Venkataramanan R, Jain AB, Warty VW, Abu-Elmagd K, Furukawa H, Imventarza O, Fung JJ, Todo S, Starzl TE. Pharmacokinetics of FK 506 following oral administration: A comparison of FK 506 and cyclosporine. Transplant Proc 23:931-933, 1991. PubMed / PDF

  31. Fung JJ, Todo S, Tzakis A, Demetris AJ, Jain AB, K Abu-Elmagd, M Alessiani, TE Starzl. Conversion of liver allograft recipients from cyclosporine to FK 506 based immunosuppression: Benefits and Pitfalls. Transplant Proc 23:14-21, 1991. PubMed / PDF

  32. Todo S, Fung JJ, Tzakis A, Demetris A, Jain AB, Alessiani M, Takaya S, Starzl TE. 110 consecutive primary orthotopic liver transplants under FK 506 in adults, Transplant Proc 23:1399-1402, 1991. PubMed

  33. Alessiani M, Kusne S, Martin M, Jain AB, Abu-Elmagd K, Moser J, Fung JJ, Starzl TE. Infection in adult liver transplant patients under FK 506 immunosuppression, Transplant Proc 23:1501-1503, 1991. PubMed / PDF

  34. McCauley J, Takaya S, Fung JJ, Tzakis A, Abu-Elmagd K, Jain AB, Todo S, Starzl TE. The question of FK 506 nephrotoxicity, Transplant Proc 23:1444-1447, 1991. PubMed / PDF

  35. Kusne S, Martin M, Shapiro R, Jordan M, Fung JJ, Alessiani M, Jain AB, Todo S, Starzl TE. Early infections in kidney transplant recipients under FK 506. Transplant Proc 23:956-957, 1991. PubMed / PDF

  36. Zeevi A, Eiras G, Kaufman C, Alessiani M, Demetris AJ, Abu-Elmagd K, Jain AB, Warty V, Venkataramanan R, Burckart G, Starzl TE, Todo S, Fung JJ, Duquesnoy R. Correlation between bio-assayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. Transplant Proc 23:1406-1408, 1991. PubMed / PDF

  37. Fung JJ, Todo S, Tzakis A, Alessiani M, Abu-Elmagd K, Jain AB, Bronsther O, Martin M, Gordon R, Starzl TE. Current status on FK 506 in liver transplantation, Transplant Proc 23:1902-1905, 1991. PubMed / PDF

  38. Alessiani M, Jain AB, Abu-Elmagd K, Todo S, Fung JJ, Starzl TE. An overview on clinical organ transplantation under FK 506, Transplant Clin Immunol 22:135-143, 1991.

  39. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain AB, Martin M, Bronsther O, Stieber A, Kormos R, Selby R, Gordon R, Starzl TE: Current status on FK 506 in organ transplantation. In: Chatelain C, Jacobs CL, eds. Seminaires D’Uro-Nephrologie. Paris, France, Masson, 1991:196-201.

  40. Steeves M, Abdallah HY, Venkataramanan R, Burckart GJ, Ptachcinski RJ, Abu-Elmagd K, Jain AB, Fung JJ, Todo S, Starzl TE. In-vitro interaction of a novel immunosuppressant, FK 506, and antacids, J Pharm Pharmacol 43:574-577, 1991. PubMed / PDF

  41. Fung JJ, Abu-Elmagd K, Jain AB, Gordon R, Tzakis A, Todo S, Takaya S, Alessiani M, Demetris AJ, Bronsther OL, Martin M, Mieles L, Selby R, Reyes J, Doyle H, Strieber A, Casavilla A, Starzl TE. A randomized trial of primary liver transplantation under immunosuppression with FK 506 versus cyclosporine, Transplant Proc 23(6):2977 -2983, 1991. PubMed / PDF

  42. Jordan ML, Shapiro R, Jensen CWB, Scantlebury V, Fung JJ, Tzakis A, McCauley J, Jain AB, Demetris AJ, Randhawa P, Simmons RL, Hakala TR, Starzl TE FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 23(6):3078-3081, 1991. PubMed / PDF

  43. Abu-Elmagd K, Fung JJ, Draviam R, Shannon W, Jain AB, Alessiani M, Takaya S, Venkataramanan R, Warty VS, Tzakis AG, Todo S, Starzl TE. Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation, Transplant Proc 23(6):2767-2770, 1991. PubMed / PDF

  44. Abu-Elmagd K, Fung JJ, Alessiani M, Jain AB, Takaya S, Venkataramanan R, Warty VS, Shannon W, Todo S, Tzakis AG, Van Thiel DH, Starzl TE. Strategy of FK 506 therapy in liver transplant patients: Effect of graft function. Transplant Proc 23(6):2771-2774, 1991. PubMed / PDF

  45. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain AB, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE. FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 23(6):3005-3006, 1991. PubMed / PDF

  46. Alessiani M, Kusne S, Fung JJ, Torre-Cisneros J, Jain AB, Abu-Elmagd K, Takaya S, Cillo U, Martin M, Todo S, Starzl TE. CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression, Transplant Proc 23:3035-3037, 1991. PubMed / PDF

  47. Eidelman BH, Abu-Elmagd K, Wilson J, Fung JJ, Alessiani M, Jain AB, Takaya S, Todo SN, Tzakis AG, Van Thiel DH, Shannon W, Starzl TE. Neurological complications of FK 506, Transplant Proc 23(6):3175-3178, 1991. PubMed / PDF

  48. Fung JJ, Alessiani M, Abu-Elmagd K, Todo S, Shapiro R, Tzakis AG, Van Thiel D, Armitage J, Jain AB, McCauley J, Selby R, Starzl TE. Adverse effects associated with the use of FK 506. Transplant Proc 23(6):3105-3108, 1991. PubMed / PDF

  49. Jain AB, Fung JJ, Tzakis AG, Venkataramanan R, Abu-Elmagd K, Alessiani M, Reyes J, Irish W, Warty V, Mehta S, Todo S, Starzl TE. Comparative study of cyclosporine and FK 506 dosage requirements in adults and pediatric orthotopic liver transplant patients, Transplant Proc PubMed / PDF

  50. Jain AB, Todo S, Fung JJ, Venkataramanan R, Day R, Bryant J, Abu-Elmagd KM, Alessiani M, Takaya S, Tzakis A, Starzl TE. Correlation of rejection episodes with FK 506 dosage, FK 506 level and steroid following primary orthotopic liver transplant, Transplant Proc 23(6):3023-3025, 1991. PubMed / PDF

  51. Jain AB, Venkataramanan R, Fung JJ, Burckart G, Emeigh J, Diven W, Warty V, Abu-Elmagd K, Todo S, Alessiani M, Starzl TE. Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. Transplant Proc 23(6):2777-2779, 1991. PubMed / PDF

  52. Roat MI, Thoft RA, Thomson AW, Jain AB, Fung JJ, Starzl TE. Treatment of Cogan’s syndrome with FK 506: A case report. Transplant Proc 23(6):3347, 1991. PubMed / PDF

  53. Shapiro R, Jordan M, Scantlebury V, Fung JJ, Jensen C, Tzakis A, McCauley J, Carroll P, Ricordi C, Demetris AJ, Mitchell S, Jain AB, Iwaki Y, Kobayashi M, Reyes J, Todo S, Hakala TR, Simmons RL, Starzl TE. FK 506 in clinical kidney transplantation. Transplant Proc 23(6):3065-3067, 1991.

  54. Tzakis AG, Reyes J, Todo S, Green M, Ohya T, Jain AB, Abu-Elmagd K, Alessiani M, Fung JJ, Starzl TE. FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 23(6):3010-3015, 1991. PubMed / PDF

  55. Tauxe WN, Mochizuki T, McCauley J, Starzl TE, Jain AB, Charron M. A comparison of the renal effects (ERPF, GFR, FF) of FK 506 and cyclosporine in patients with liver transplantation, Transplant Proc 23(6):3146-3147, 1991. PubMed / PDF

  56. Venkataramanan R, Jain AB, Warty VS, Abu-Elmagd K, Alessiani M, Lever J, Krajack A, Flowers J, Mehta S, Zuckerman S, Fung JJ, Todo S, Starzl TE. Pharmacokinetics of FK 506 in transplant patients, Transplant Proc 23(6):2736-2740, 1991. PubMed / PDF

  57. Whiteside, J Wilson, J Bryant, A Zeevi, K Abu-Elmagd, AB Jain, M Alessiani, JJ Fung, RB Herberman, TE Starzl. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood or transplanted patients randomized to cyclosporine A or FK 506. Transplant Proc 23(6):3047-3051, 1991. PubMed / PDF

  58. McCauley J, Fung JJ, Brown H, Deballi P, Jain AB, Todo S, Starzl TE. Renal function after conversion from cyclosporine to FK 506 in liver transplant patients, Transplant Proc 3(6):3148-3149, 1991. PubMed / PDF

  59. McCauley J, Shapiro R, Bronsther O, Jordan M, Ellis D, Gilboa N, Scantlebury V, Jensen C, Jain AB, Starzl TE. Renal transplantation under FK 506 in patients with previous loss of renal function due to hemolytic uremic syndrome, Transplant Proc 23(6):3068-3070, 1991. / PDF

  60. McCauley J, Fung JJ, Todo S, Jain AB, Deballi P, Starzl TE. Changes in renal function after liver transplantation under FK 506, Transplant Proc 23(6):3143-3145, 1991. PubMed / PDF

  61. Fung JJ, Abu-Elmagd K, Todo S, Shapiro R, Tzakis A, Jordan M, Armitage J, Jain AB, Martin M, Bronsther O, Strieber A, Kormos R, Selby R, Gordon R, Starzl TE. FK 506 in clinical organ transplantation. Clin Transplant 5:517-522, 1991. / PDF

  62. Takaya S, Bronsther O, Todo S, Abu-Elmagd K, Jain AB, Alessiani M, Madariaga J, Marino IR, Selby R, Fung JJ, Gordon RD, Starzl TE. Retransplantation of liver: A comparison of FK 506-and cyclosporine-treated patients. Transplant Proc 23(6):3026-3028, 1991. PubMed / PDF

  63. Felser I, Wagner S, Depee J, Johnson N, Staschak S, Jain AB, Fung JJ, Starzl TE. Changes in quality of life following conversion from CYA to FK 506 in orthotopic liver transplant patients. Transplant Proc 23(6):3032-3034, 1991. PubMed / PDF

  64. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain AB, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl TE. Conversion of liver allograft recipients from cyclosporine to FK 506 immunosuppressive therapy–A clinicopathologic study of 96 patients, Transplantation 53:1056-1062, 1992. PubMed / PDF

  65. Zeevi A, Venkataramanan R, Warty V, Eiras G, Woan M, Abu-Elmagd K, Alessiani M, Jain AB, Demetris AJ, Zerbe T, Fung JJ, Todo S, Starzl TE, Duquesnoy RJ. In vitro assessment of FK 506 immunosuppressive activity in transplant patients, Transplant Proc 3:2897-2899, 1991. PubMed / PDF

  66. Reyes J, Abu-Elmagd K, Tzakis A, Nour B, Casavilla A, Kusne S, Green M, Alessiani M, Jain AB, Fung JJ, Todo S, Starzl TE. Infectious complications after human small bowel transplantation, Transplant Proc 24(3):1249-1250, 1992. PubMed / PDF

  67. Jain AB, Venkataramanan R, Todo S, Abu-Elmagd K, Fung JJ, Warty V, Tzakis A, Reyes J, Alessiani M, Starzl T. Intravenous, oral pharmacokinetics and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 24(3):1181-1182, 1992. PubMed / PDF

  68. Kusne S, Fung JJ, Alessiani M, Martin M, Torre-Cisneros J, Irish W, Ondick L, Jain AB, Abu-Elmagd K, Takaya S, Todo S, Starzl TE. Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation, Transplant Proc 24(1):429-430, 1992. PubMed / PDF

  69. Todo S, Tzakis AG, Abu-Elmagd K, Reyes J, Fung JJ, Casavilla A, Nakamura K, Yagihashi A, Jain AB, Murase N, Iwaki Y, Demetris AJ, Van Thiel DH, Starzl TE. Cadaveric small bowel and small bowel-liver transplantation in humans, Transplantation 53(2):369-376, 1992. PubMed / PDF

  70. Shapiro R, Jordan ML, Scantlebury VP, Fung JJ, Jensen C, Vivas C, McCauley J, Irish WD, Mitchell S, Demetris AJ, Randhawa P, Jain AB, Tzakis A, Hakala TR, Simmons RL, Starzl TE. Randomized trial of FK 506/Prednisone versus FK 506/Azathioprine/Prednisone after renal transplantation: Preliminary report. Transplant Proc 25(1 Pt. 1):669-672, 1993. / PDF

  71. Alessiani M, Cillo U, Fung JJ, Irish W, Abu-Elmagd K, Jain AB, Takaya S, Van Thiel D, Starzl TE: Adverse effects of FK 506 over-dosage after liver transplantation. Transplant Proc 25(1 Pt 1):628-634, 1993. PubMed / PDF

  72. Jain AB, Venkataramanan R, Lever J, Warty V, Fung JJ, Todo S, Starzl TE. FK 506 and pregnancy in liver transplant patients. Transplantation 56(3):751, 1993. PubMed / PDF

  73. Fung JJ, Todo S, Abu-Elmagd K, Jain AB, Tzakis A, Martin M, Selby R, Bronsther O, Doyle H, Gayowski T, Ramos H, Kishida A, Starzl TE. A randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine, Transplant Proc 25(1 Pt. 2):1130, 1993. PubMed / PDF

  74. Jain AB, Abu-Elmagd K, Abdallah H, Warty V, Fung JJ, Todo S, Starzl TE, Venkataramanan R. Pharmacokinetics of FK 506 in liver transplant recipients following continuous intravenous infusion. J Clin Pharmacol 33(7):606-611, 1993. PubMed / PDF

  75. Abu-Elmagd K, Bronsther OL, Jain AB, Irish W, Ramos H, Marino I, Dodson F, Selby R, Doyle H, Furukawa H, Gaywoski T, Nour B, Reyes J, Mazariegos G, Pinna A, Rao AS, Fontes PA, Casavilla A, Jabbour N, Marsh W, Madariaga J, Demetris A, Tzakis A, Todo S, Iwatsuki S, Fung JJ, Starzl TE: Recent Advances in Hepatic Transplantation at the University of Pittsburgh. In: Terasaki and Cecka, eds. Clinical Transplants 1993 Los Angeles, CA, UCLA Tissue Typing Laboratory, 1993:137-152. PubMed / PDF

  76. Jain AB. Incidence and severity of rejection under Alpha Interferon for viral hepatitis following liver transplantation. Liver update, Function and Disease 7(1):5, 1993.

  77. Venkataramanan R, Lever J, Jain AB, Burckart G, Flowers J, Warty VS, Fung JJ, Todo S, Starzl TE. FK 506: Correlation between trough concentration and AUC in transplant patients. Pharm Res 10(10):390, 1993.

  78. Jain AB, Venkataramanan R, Lever J, Warty V, Abu-Elmagd K, Furukawa H, Reyes J, Nour B, Asrian A, Tzakis A. FK 506 in small bowel transplant recipients: Pharmacokinetics and dosing. Transplant Proc 25(3):1609-1610, 1994. PubMed / PDF

  79. Manez R, Martin M, Raman D, Silverman D, Jain AB, Warty V, Gonzalez-Pinto I, Kusne S, Starzl TE. Fluconazole therapy in transplant recipients receiving FK 506, Transplantation 57(10):1521-1523, 1994. PubMed

  80. Todo S, Fung JJ, Starzl TE, Tzakis A, Doyle H, Abu-Elmagd K, Jain AB, Selby R, Bronsther O, March W, Ramos H, Reyes J, Gayowski T, Casavilla A, Dodson F, Furukawa H, Marino I, Pinna A, Nour B, Jabbour N, Mazariegos G, McMichael J, Kusne S, Venkataramanan R, Warty V, Murase N, Demetris AJ, Iwatsuki S. Single center experience with primary orthotopic liver transplantation under FK 506 immunosuppressive. Ann Surg 220(3):297-309, 1994. PubMed / PDF

  81. Shapiro R, Jordan ML, Scantlebury VP, Vivas C, Fung JJ, McCauley J, Randhawa P, Demetris AJ, Irish W, Jain AB, Mitchell S, Hakala TR, Simmons RL, Starzl TE. A prospective, randomized trial of FK 506/Prednisone versus FK 506/Azathioprine/Prednisone in renal transplant patients, Transplant Proc 27(1):814-817, 1995. PubMed / PDF

  82. Jain AB, Fung JJ, Todo S, Reyes J, Selby R, Irish W, Doyle H, Abu-Elmagd K, Casavilla A, Nour B, Bronsther O, Jabbour N, Pinna A, Dodson F, Ramos H, McMichael JJ, McCauley J, Tzakis AG, Marino I, Marsh W, Venkataramanan R, Iwatsuki S, Starzl TE. One thousand consecutive primary orthotopic liver transplants under FK 506: Survival and adverse events. Transplant Proc 27(1):1099-1104, 1995. PubMed / PDF

  83. Bronsther O, Manez R, Kusne S, Irish W, Roland W, Jain AB, Demetris AJ, Starzl TE. Post-transplant B, Non-A Non-B, and cytomegalovirus hepatitis increases the risk of developing chronic rejection after liver transplantation. Transplant Proc 27(1):1206-1207, 1995. PubMed / PDF

  84. Jain AB, Pinna A, Fung JJ, Warty VS, Singhal AK, Lever J, Venkataramanan R. Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation 60:512-514, 1995. PubMed / PDF

  85. Tasamandas A, Jain AB, Raikow RB, Demetris AJ, Nalesnik MA, Randhawa PS. Extra medullary hematopoiesis in the allograft liver. Modern Pathol 8(6):671-674, 1995. PubMed

  86. Manez R, Jain AB, Marino IR, Thomson A. Comparative evaluation of tacrolimus (FK 506) and cyclosporine A as immunosuppressive agents (review). Transplant Rev 9(2):63-76, 1995.

  87. Abu-Elmagd, K, Fung J, Todo S, Rao A, Reyes J, Mazariegos G, Fontes P, McMichael J, Furukawa H, Dodson F, Jain AB, Pinna A, Marsh W, Marino I, Gayowski T, Doyle H, Adariaga J, Casavilla A, Demetris J, Corry R, Rakela J, Iwatsuki S, Starzl TE. The current status of hepatic transplantation at the University of Pittsburgh, In: Clinical Transplants 1995 (P Terasaki, F Cecka, eds.), UCLA Tissue Typing Laboratory, Los Angeles, CA, 1995:145-170. / PDF

  88. Venkataramanan R, Swaninathan A, Prasad T, Jain AB, Zuckerman S, Warty VS, McMichael J, Lever J, Burckart G, Starzl TE. Clinical Pharmacokinetics of Tacrolimus, Clin Pharmacokinetic 29(6):404-430, 1995. PubMed

  89. Pham SM, Kormos R, Hatler BG, Kawai A, Tasamandas AC, Demetris AJ, Murali S, Fricker FJ, Chang HC, Jain AB, Starzl TE, Hardesty RL, Griffith BP. Cardiac and pulmonary replacement: A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results. J Thoracic Cardiovasc Surg 111(4):764-772, 1996. PubMed / PDF

  90. Jain AB, Fung JJ. Cyclosporine and tacrolimus in clinical transplantation: A comparative review. Clin Immunother (5):351-373, 1996. / PDF

  91. Fung JJ, Todo S, Jain AB, Demetris AJ, McMichael JP, Starzl TE. The Pittsburgh randomized trial of tacrolimus versus Cyclosporine for liver transplantation. J Am Coll Surg 183(2)117-125, 1996. PubMed / PDF

  92. Tabasco-Minguillan J, Jain AB, Naik M, Weber KM, Irish W, Fung JJ, Rakela J, Starzl TE. Gastrointestinal bleeding after liver transplantation, Transplantation 63(1):60-67, 1997. PubMed / PDF

  93. Khanna A, Jain AB, Ziady G, Demetris AJ, Fung JJ, Kramer D, Starzl TE. Cardiac changes at autopsy in adult liver transplant recipients under tacrolimus. Transplant Proc 29(1-2):532-533, 1997. PubMed PDF

  94. Jain AB, Venkataramanan R, Fung JJ, Gartner JC, Lever J, Balan V, Warty V, Starzl TE. Pregnancy after liver transplantation under tacrolimus, Transplantation 64(4):559-565, 1997. PubMed / PDF

  95. Tasamandas AC, Jain AB, Felekouras ES, Fung JJ, Demetris AJ, Lee RG: Central venulitis in the allograft liver. Transplantation 64(2):252-257, 1997. PubMed / PDF

  96. Jain AB, Demetris AJ, Manez R, Tasamandas AC, Van Thiel D, Rakela J, Starzl TE, Fung JJ. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alpha-interferon. Liver Transplantation and Surg 4(3):197-203, 1998. PubMed / PDF

  97. Torbenson M, Wang J, Nichols L, Jain AB, Fung JJ, Nalesnik MA. Causes of death in autopsied liver transplant patients, Mod Pathol 11(1):37-46, 1998. PubMed

  98. Burckart GJ, Frye RF, Kelly P, Branch RA, Jain AB, Fung JJ, Starzl TE, Venkataramanan R. Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6- hydroxylation, Clin Pharmacol Ther 63(3):296-302, Mar, 1998. PubMed / PDF

  99. Jain A, Reyes J, Kashyap R, Rohal S, Cacciarelli T, McMichael J, Rakela J, Starzl TE, Fung JJ. Liver transplantation under tacrolimus in infants, children, adults and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc 30(4):1403-1404, 1998. PubMed / PDF

  100. DiMartini A, Jain AB, Irish W, Fitzgerald MG, Fung JJ. Outcome of liver transplantation in critically ill alcoholic cirrhosis: Survival according to medical variables and society. Transplantation 66(3):298-302, 1998. PubMed / PDF

  101. Jain AB, Yee LD, Nalesnik MA, Youk A, Marsh J, Reyes J, Rakela J, Irish W, Fung JJ. Comparative incidence of de novo non-lymphoid malignancies after liver transplantation under Tacrolimus using surveillance epidemiologic end-result data, Transplantation 66(9):1193-1200, 1998. PubMed / PDF

  102. Cacciarelli TV, Green M, Jaffee R, Mazariegos GV, Jain AB, Fung JJ, Reyes J. Management of post-transplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 66(8):1047-1052, 1998. PubMed

  103. Abu-Elmagd K, Fung J, Reyes J, Rao A, Jain AB, Mazariegos G, Marsh J, Madariaga J, Dvorchik I, Bueno J, Rogers J, McMichael J, Dodson F, Vargas H, Martin J, Slivka A, Balan V, Corry R, Rakela J, Murase N, Iwatsuki S, Starzl T. Hepatic and intestinal transplantation at the University of Pittsburgh. Clin Transpl 263-286, 1998 PubMed / PDF

  104. Jain AB, Gadomski M, Fung, JJ. Conversion from cyclosporine to Neoral in stable adult liver transplant recipients, Dig Dis Sci 44(4):775-77, 1999. PubMed / PDF

  105. Jain AB, Fung JJ, Kashyap R, Rakela J, Starzl TE. Primary adult liver transplantation under tacrolimus: More than 90 months’ actual follow-up survival and adverse events. Liver Transpl Surg 5(2):144-150, 1999. PubMed / PDF

  106. Molmenti E, Jain AB, Marino N, Rishi N, Dvorchik I, Marsh J. Liver transplantation and pregnancy. Clin Liver Dis 3(1):163-174, 1999

  107. Jain AB, Khanna A, Molmenti EP, Rishi N, Fung JJ. Immunosuppressive therapy: New concepts. Surg Clin North Amer 79(1):59-76, 1999. PubMed / PDF

  108. Jain AB, Hamad I, Zuckerman S, Warty VS, Fung JJ, Venkataramanan R. Effect of T-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of Mycophenolate Mofetil. Liver Transpl Surg 5(2):101-106, 1999. PubMed / PDF

  109. Jain AB, Reyes J, Kashyap R, Rohal S, Abu-Elmagd K, Starzl TE, Fung JJ. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow up of the first 1000 patients, Ann Surg 230(3):441-449, 1999. PubMed PDF

  110. Cacciarelli TV, Dvorchik K, Mazariegos GV, Gerber D, Jain AB, Fung JJ, Reyes J. An analysis of pre-transplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK 506) therapy. Transplantation 68(5):650-655, 1999. PubMed

  111. Jain AB, Kashyap R, Fung JJ: Current perspective on immunosuppression used in liver transplantation with emphasis on neurotoxicity. Gastroenterology Intern 12(3):115-122, 1999.

  112. Takaya S, Jain A, Yagihashi A, Nakamura K, Kobayashi M, Tekeuchi K, Suzuki S, Iwaki Y, Demetris AJ, Todo S, Fung JJ, Starzl TE. Increased bile duct complications and/or chronic rejection in cross match-positive human liver allografts. Transplant Proc 31(5):2028-2031, 1999. PubMed / PDF

  113. Molmenti E, Mazariegos G, Bueno J, Cacciarelli T, Alasia T, Khanna A, Kosmach B, Jain A, Fung J, Reyes J. Noncompliance after pediatric liver transplantation. Transplant Proc 31(1-2):408, 1999. PubMed PDF

  114. Khanna A, Jain A, Eghtesad B, Rakela J. Liver transplantation for metabolic liver diseases. Surg Clin North Am 79(1):59-76, 1999. PubMed / PDF

  115. 115. Shapiro R, Jordan ML, Scantlebury VP, Vivas CA, Jain AB, Chakrabarti P, McCauley J, Johnston J, Randhawa P, Rao A, Fung JJ, Corry RJ. Simultaneous pancreas-kidney transplantation at the University of Pittsburgh, Clin Transpl 217-221, 1999 PubMed

  116. Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, Jain AB, Vivas C, Ellis D, Lombardozzi-Lane S, Randhawa P, Johnston J, Hakala TR, Simmons RL, Fung JJ, Starzl TE: Post-transplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999; 68(12):1851-1854. PubMed / PDF

  117. Jain AB, Hamad I, Brody D, Fung JJ. Conversion to Neoral for neurotoxicity after primary adult liver transplantation under tacrolimus, Transplantation 69(1):172-176, 2000. PubMed / PDF

  118. Jain A, DiMartini A, Kashyap R, Youk A, Rohal S, Fung JJ. Long-term follow up after liver transplantation for alcoholic liver disease under tacrolimus, Transplantation 2000; 70(9):1335-1342. PubMed PDF

  119. Reyes J, Jain AB, Mazariegos G, Kashyap R, Green M, Iurlano K, Fung JJ. Long-term results after conversion from Cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection, Transplantation 69(12):2573-2580, 2000. PubMed / PDF

  120. Jain AB, Mazariegos G, Kashyap R, Green M, Gronsky C, Starzl TE, Fung JJ, Reyes J. Comparative long-term evaluation of tacrolimus and Cyclosporine in pediatric liver transplantation. Transplantation 70(4):617-625, 2000. PubMed / PDF

  121. Blakolmer K, Jain AB, Ruppert K, Gray E, Duquesnoy R, Murase N, Starzl TE, Fung JJ, Demetris JJ. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: Long-term follow up and evaluation of features for histopathological staging. Transplantation 69(11):2330-2336, 2000. PubMed / PDF

  122. Jain AB, Reyes J, Kashyap R, Dodson F, Demetris AJ, Ruppert K, Abu-Elmagd K, Marsh J, Madariaga J, Mazariegos G, Geller D, Bonham AC, Gayowski T, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center, Ann Surg 232(4):490-500, 2000. PubMed / PDF

  123. Jain AB, Jorge Reyes, Randeep Kashyap, Forrest Dobson, Anthony J. Demetris, Kris Ruppert, Kareem Abu-Elmagd, Wallis Marsh, Juan Madariaga, George Mazariegos, David Geller, C. Andrew Bonham, Timothy Gayowski, Thomas Cacciarelli, Paulo Fontes, Thomas E. Starzl, John Fung. Long-Term Survival after Transplantation in 4,000 Consecutive Patients at a Single Center. Ann Surg, Vol. 232 (4), (October), 2000: pp. 490-500 PubMed PDF / PDF

  124. DiMartini A, Magill J, Fitzgerald MG, Jain AB, Irish W, Khera G, Yates W. Use of a high-risk alcohol relapse scale in evaluating liver transplant candidates. Alcoholism: Clinical & Experimental Research 24(8):1198-1201, 2000. PubMed PDF

  125. Shapiro R, Jordan M, Scantlebury VP, Vivas CA, Jain AB, McCauley J, Egidi MF, Randhawa P, Chakrabarti P, Corry RJ. Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients: Does dissynchronous rejection really exist? Transplantation 2000; 69(3):440-442.PubMed / PDF

  126. Jain AB, Hamad I, Rakela J, Dodson F, Kramer D, Demetris J, McMichael J, Starzl TE, Fung JJ. A prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplant recipients: an interim report. Transplant Proc (33):1342-1344, 2001. PubMed PDF

  127. Jain AB, Venkataramanan R, Hamad IS, Zuckerman S, Zhang S, Lever J, Warty VS, Fung JJ. Pharmacokinetics of mycophenolic acid after Mycophenolate Mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol 41(3)268-276, 2001 PubMed PDF

  128. Jain AB, Kashyap R, Fung JJ. An overview of liver transplantation under tacrolimus, Journal of Transplantation in Developing Nations 2(1-2):7-12, March-June 2001.

  129. Jain AB, Mazariegos G, Kashyap R, Marsh J, Khanna A, Iurlano K, Fung JJ, Reyes J. Reasons why some children receiving tacrolimus therapy require steroids more than five years post-liver transplantation. Ped Transplantation 5:93-98, 2001. PubMed / PDF

  130. Jain AB, Kashyap R, Marsh J, Rohal S, Khanna A, Fung JJ. Reasons for long-term use of steroids in primary adult liver transplantation under tacrolimus, Transplantation 71(8):1102-1106, 2001. PubMed PDF

  131. Luke PPW, Scantlebury VP, Jordan ML, Vivas CA, Hakala TR, Jain AB, Somani A, Fedorek S, Randhawa P, Shapiro R. Reversal of steroid-and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients. Transplantation 2001;72(3); 419-422. PDF

  132. Kashyap R, Jain AB, Reyes J, Demetris AJ, Abu-Elmagd KA, Dodson SF, Marsh J, Madariaga J, Mazariegos G, Geller D, Bonham, CA, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Causes of re-transplantation after primary liver transplantation in 4,000 consecutive patients: 2 to 19 years’ follow up, Transplant Proc 33(1-2):1486-1487, 2001. PubMed PDF

  133. Kashyap R, Jain AB, Reyes J, Demetris AJ, Abu-Elmagd K, Dodson S, Marsh J, Mazariegos G, Geller D, Bonham CA, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Causes of death after liver transplantation in 4,000 consecutive patients: 2-19 years’ follow up, Transplant Proc 33(1-2) 1482-1483, 2001 PubMed PDF

  134. Jain AB, Kashyap R, Kramer D, Dodson F, Hamad I, Starzl TE, Fung JJ Prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil: A complete report on 350 primary adult liver transplantations. Transplant Proc 33(1-2)1342-1344, 2001 PubMed PDF

  135. Torbenson M, Wank J, Nichols L, Jain AB, Fung JJ, Nalesnik MA. Occult non-hematopoietic malignancies present at autopsy in solid-organ transplant patients who died within 100 days. Transplantation 71(1):64-69, 2001 PubMed PDF

  136. Molmenti EP, Jain AB, Shapiro R, Scantlebury V, Lee R, Totsuka E, Flohr J, Rakela J, Fung JJ. Kidney transplantation for end-stage renal failure in liver transplant recipients with hepatitis C viral infection, Transplantation 71(2):267-270, 2001. PubMed PDF

  137. DiMartini A, Day N, Dew MA, Lane T, Fitzgerald MG, Magill J, Jain AB. Alcohol use following liver transplantation: A comparison of follow-up methods. Psychosomatics 42(a):55-62, 2001. PubMed PDF

  138. Randhawa P, Blakolmer K, Kashyap R, Raikow R, Nalesnik, M, Demetris AJ, Jain AB. Allograft liver biopsy in patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease. Am J Surg Pathol (3)324-330, 2001. PubMed PDF

  139. Luke PPW, Scantlebury VP, Jordan ML, Vivas CA, Hakala TR, Jain AB, Somani A, Fedorek S, Randhawa P, Shapiro R. IVIG rescue therapy in renal transplantation. Transplant Proc 33:1093-1094, 2001. PubMed PDF

  140. McCauley J, Shapiro R, Jordan ML, Scantlebury VP, Vivas V, Jain AB, Good D, Woods H, Johnston J, Corry RJ. Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression, Transplant Proc 33:1698-1699, 2001. PubMed PDF

  141. Shapiro R, Rao AS, Corry RJ, Valenti M, Zeevi A, Jordan ML, Scantlebury VP, Vivas A, Jain AB, McCauley J, Randhawa P, Gray EA, Dvorchik I, McMichael J, Fung JJ, Starzl TE. Kidney transplantation with bone marrow augmentation-five year outcomes, Transplant Proc 33(1-2)1134-1135, 2001 PubMed / PDF

  142. Chakrabarti P, Wong HY, Toyofuku A, Scantlebury VP, Jordan ML, Vivas C, Jain AB, McCauley J, Johnston J, Randhawa PS, Hakala TR, Simmons RL, Fung JJ, Starzl TE, Shapiro R. Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc 33(1-2):1235-1236, 2001. PubMed / PDF

  143. Shapiro R, Randhawa P, Jordan ML, Scantlebury VP, Vivas C, Jain AB, Corry RJ, McCauley J, Johnston J, Donaldson J, Gray EA, Dvorchik I, Hakala TR, Fung JJ, Starzl TE. An analysis of early renal transplant protocol biopsies-the high incidence of sub-clinical tubulitis, Am J Transplantation 1(1):47-50, 2001. PubMed / PDF

  144. Jain AB, Demetris A, Kashyap R, Blakomer K, Ruppert K, Khan A, Rohal S, Starzl TE, Fung JJ. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1048 liver transplantations with a mean follow up of six years, Liver Transplantation 7(7):623-630, 2001. PubMed / PDF

  145. Cacciarelli TV, Reyes J, Jaffe R, Mazariegos GV, Jain AB, Fung JJ, Green M. Primary tacrolimus (FK 506) therapy and the long-term risk of post-transplant lymphoproliferative disease in pediatric liver transplant recipients. Ped Transplantation 5:359-364, 2001. PubMed / PDF

  146. Bellamy COC, DiMartini AM, Ruppert K, Jain AB, Dodson F, Torbenson M, Starzl TE, Fung JJ, Demetris AJ. Liver transplantation for alcoholic cirrhosis: Long-term follow up and impact of disease recurrence. Transplantation 72(4):619-626, 2001. PubMed / PDF

  147. Jain AB, Kashyap R, Dodson SF, Kramer D, Hamad I, Khan A, Eghtesad B, Starzl TE, Fung JJ. A prospective randomized trial of tacrolimus and Prednisone versus tacrolimus, Prednisone and Mycophenolate Mofetil in primary adult liver transplantation: A single center report. Transplantation 72(6); 1091-1097, 2001 PubMed / PDF

  148. Fung JJ, Jain AB, Kwak EJ, Kusne S, Dvorchik I, Eghtesad B. De novo malignancies after liver transplantation: A major cause of late death. Liver Transplantation 7(11)1, November 2001: S109-S118. PubMed / PDF

  149. Kashyap R, Jain AB, Nalesnik M, Carr BI, Barnes J, Vargas HE, Rakela J, Fung JJ. Clinical significance of elevated alpha-fetoprotein in adults and children, Digestive Diseases and Sciences 46(8): August 2001, 1709-1713. PubMed / PDF

  150. Mazariegos GV, Salzedas, AA, Jain AB, and Reyes JA. Conversion from Cyclosporine to tacrolimus in pediatric liver transplant recipients, Pediatric Drugs 2001; 3(9):661-672. PubMed

  151. Donnenberg, V.S., G. J. Burckart, Griffith, B. P., Jain AB., Zeevi, A., Berg, A.D. (2001). “P- Glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients.” J Clin Pharmacol 41 (12): 1271-9. PubMed / PDF

  152. Venkataramanan, R., L. M. Shaw, Sarkozi, L., Mullins, R., Pirsch, J., MacFarlane, G., Scheller, D., Ersfeld, D., Frick, M., Fitzsimmons, W. E., Virji, M., Jain AB., Brayman, K. L., Shaked, A. (2001) “Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients.” J Clin Pharmacol 41(5): 542-51. PubMed / PDF

  153. Jain AB, Mazariegos G, Kashyap R, Beverly K, Starzl TE, Fung JJ, Reyes J. Pediatric liver transplantation: A single center experience spanning 20 years. Transplantation 73:(6):941-947, March 27, 2002. PubMed / PDF

  154. Daly I, Jain AB, Reyes J, Fung JJ. Mycophenolate Mofetil for treatment of chronic rejection in liver allograft under tacrolimus, Transplant Proc 34:1503 2002 PDF

  155. Jain AB, Mazariegos G, Pokharna R, Parizhskaya M, Smith A, Kashyap RS, Fung JJ, Reyes, J. Almost Total Absence of Chronic Rejection in Primary Pediatric Liver Transplantation Under Tacrolimus. Transplant Proc 34:1968-1969 (2002). PubMed / PDF

  156. Jain AB, Mazariegos G, Kashyap RS, Kosmach-Park B, Starzl TE, Fung JJ, Reyes J. Pediatric Liver Transplantation in 808 Consecutive Children: 20 Years’ Experience from a Single Center, Transplant Proc 34:1955-1957 (2002). PubMed / PDF

  157. Jain AB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Pokharna R, Rohal S, Ragni M, Fung JJ. The Interaction between Tacrolimus and Anti-Retroviral Agents in HIV-Positive Liver and Kidney Transplant Patients, Transplant Proc 34:1540-1541 (2002). PubMed / PDF

  158. Jain AB, Pokharna R, Eghtesad B, Potdar S, Kashyap RS, Kingery L, Fung JJ. Steroid Withdrawal under Tacrolimus for Primary Biliary Cirrhosis (PBC), Primary Sclerosing Cholangitis (PSC) and Autoimmune Hepatitis (AIH) After Liver Transplantation and Long-Term Survival, Transplant Proc 34:1524-1525 (2002). PubMed / PDF

  159. Jain AB, Kashyap R, Demetris AJ, Eghtesad B, Pokharna R, Fung JJ. A prospective randomized trial of Mycophenolate Mofetil in liver transplant recipients with hepatitis C. Liver Transplantation 8(1): 40-6 January 2002 PubMed / PDF

  160. Jain AB, Nalesnik M, Reyes J, Pokharna R, Mazariegos G, Green M, Eghtesad B, Marsh W, Cacciarelli T, Fontes P, Abu-Elmagd K, Sindhi R, Demetris J, Starzl T and Fung J. Post-transplant lymphoproliferative disorders (PTLD) in liver transplantation (LTx): A twenty year experience. Annals of Surgery 236(4): October 2002, 429-437. PubMed / PDF

  161. Jain AB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Ragni M, Fung JJ. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients, Liver Transplantation 8:(9); September 2002; 841-845. PubMed / PDF

  162. Jain AB, Venkataramanan R., Fridell JA, Eghtesad B, Ragni M, Fung JJ. Nelfinavir, a protease inhibitor, increases sirolimus levels in liver transplant patients: A case report. Liver Transplantation 8:(9) September 2002, 838-840 PubMed PDF

  163. Agarwala S, Culligan E, Jain AB, McCauley J, Shapiro R, Chakrabarti P, Burckart G. Evaluation of renal function in transplant patients on chronic tacrolimus therapy. J Clinical Pharmacology 42:(7) 798-805, 2002 PubMed / PDF

  164. Demetris AJ, Ruppert K, Dvorchik I, Jain AB, Minevini M, Nalesnik, MA, Randhawa P, Wu T, Zeevi A, Abu-Elmagd K, Eghtesad B, Fontes PA, Cacciarelli TV, Marsh JW, Geller DA, Fung JJ. Real-Time Monitoring of Acute Liver-Allograft Rejection Using the Banff Schema, Transplantation 74(9):1290-1296, November 15, 2002. PDF

  165. Jain AB, Eghtesad B, Venkataramanan R, Fontes PA, Kashyap R, Dvorchik I, Shakil AO, Kingery L and Fung JJ. Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection. Liver Transplantation 8:(11); November 2002: 1007-1013 PDF

  166. Shapiro R, Scantlebury VP, Jordan ML, Vivas CA, Jain AB, Hakala TR, McCauley J, Johnston J, Randhawa P, Fedorek S, Gray E, Chesky A, Dvorchik I, Donaldson J, Fung-JJ, and Starzl TE. A pilot trial of tacrolimus, sirolimus and steroids in renal transplant recipients. Transplant Proc 34:1651-1652 (2002). PDF

  167. Jain AB, Venkataramanan R, Shapiro R, Scantlebury VP, Potdar S, Bonham CA, Pokharna R, Rohal S, Ragni M, and Fung JJ. Interaction between tacrolimus and antiretroviral agents in human immunodeficiency virus-positive liver and kidney transplantation patients. Transplant Proc 34:1540-1541 (2002). PubMed / PDF

  168. Fridell, J. A., Jain AB, Reyes, J., Beiderman, R., Green, M., Sindhi, R., Mazariegos, G.V. (2002). “Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus.” Transplantation 74(12):1721-4. PubMed / PDF

  169. Jain AB, Yue, Z, Chunping, J, Fung, J. J, Retransplantation-the only means to save recipients life after failure of liver transplantation: a report of 774 cases Chin J. Hepatobiliary Surg, Nov 2002, Vol. 8, No. 11.

  170. Yue, Z, Jain AB, Fung, J. J. Long-Term Survival after Liver Transplantation in 4000 Consecutive Patients at a Single Center. 12th Annual Meeting of the American Surgical Association, April 6-8, 2000, Pennsylvania. Ann Surg, Chin J., Volume 232 (4) October 2002. pp. 490-500.

  171. Shullo MA, Rose ML, Vivas C, Jain AB, et al. Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy 2002; 22 (2): 184 PubMed / PDF

  172. Jain AB, Mike Nalesnik, Jorge Reyes, Renu Pokharna, George Mazariegos, Michael Green, Bijan Eghtesad, Wallis Marsch, Thomas Cacciarelli, Paulo Fontes, Kareem Abu-Elmagd, Rakesh Sindhi, Jake Demetris, John Fung. Post-transplant Lymphoproliferative Disorder in Liver Transplantation: A 20 Year Experience. Ann Surg, Vol 236 (4), (October), 2002: pp. 429-437. PubMed / PDF

  173. Fridell JA, Bond GJ, Mazariegos GV, Jain AB et al Liver Transplantation in children with cystic fibrosis: a long term longitudinal review of a single centre experience. Journal of Pediatric Surgery 2003; 38 (8):1152 PDF

  174. Fridell, J.A., A. K. Jain AB, Patel, K., Virji, M., Rao, K. N., Fung, J. J., Venkataramanan, R. (2003). “Phenytoin decreases the blood concentrations of sirolimus in a liver transplant recipient: a case report.” The Drug Monit 25 (1): 117-9. PDF

  175. Jain AB. and J. J. Fung (2003). “Advances in hepatitis B virus infection.” Transplant Proc 35(1) 342-4. PubMed / PDF

  176. Jain AB and J. J. Fung (2003). “Alcoholic liver disease and transplantation.” Transplant Proc 35(1): 358-60. PubMed / PDF

  177. Jain AB and J. J. Fung. Fung (2003). “Hepatitis C virus and renal failure.” Transplant Proc 35(1): 416-8. PubMed / PDF

  178. Eghtesad, B., Jain AB. and J. J. Fung (2003). “Living donor liver transplantation: ethics and safety.” Transplant Proc 35(1): 51-2. PubMed / PDF

  179. Jain A, Mazariegos G, Pokharna r, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J., The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplant 2003 April 15; 75 (7):1020-5. / PDF

  180. Torbenson M, Wang J, Nichols L, Jain A, Fung J, Nalesnik MA, Cauases of death in autopsied liver transplantation patients. Mod. Pathol. 1988 Jan; 11(1):37-46

  181. Jain AB, Raman Venkataramanan, Bijan Eghtesad, Amadeo Marcos, Margaret Ragni, Ron Shapiro, Ann B. Rafail, and John J. Fung. Effects of Co-administered Lopinavir and Ritonavir (Kaletra) on Tacrolimus Blood Concentration in Liver Transplantation Patients. Liver Transplantation, Vol 9 (September), 2003: p 954-960. PubMed / PDF

  182. Jain AB, J. Reyes, Amadeo Marcos, G. Mazariegos, Bijan Eghtesad, Paulo A. Fontes, Thomas V. Cacciarelli, J. Wallis Morsch, Michael E. De Vera, Ann Rafail, Thomas E. Starzl, and John J. Fung. Pregnancy after Liver Transplantation with Tacrolimus Immunosuppression: A single Center’s Experience update at 13 years. Transplantation: Vol. 76, 827-932, No. 5, September 15, 2003. PubMed / PDF

  183. Luke PP, Herz DB, Bellinger MF, Chakrabarti P, Vivas CA, Scantlebury VP, Hakala TR, Jevnikar AM, AB Jain, Shapiro R, Jordan ML. Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation. 2003 Dec 15;76(11):1578-82 PubMed / PDF

  184. Eghtesad B, Marsh WJ, Cacciarelli T, Geller D, Reyes J, AB Jain, Fontes P, Devera M, Fung J. Liver transplantation for growing teratoma syndrome: report of a case. Liver Transpl. 2003 Nov;9(11):1222-4. PubMed / PDF

  185. Cataldo Doria, Jain AB, Victor L. Scott, Salvatore Gruttadauria, Ignazio R. Marino, Howard R. Doyle, John J. Fung, Conversion from tacrolimus to cyclosporine-A based immunosuppression following liver transplantation. Experimental and Clinical Transplantation (2003) 1:48-55.

  186. Jain AB, Shapiro R, Scantlebury VP, Potdar S, Jordan ML, Flohr J, Marcos A, Fung JJ. Pregnancy after kidney and kidney-pancreas transplantation under tacrolimus: a single center’s experience. Transplantation. 2004 Mar 27;77(6):897-902 PubMed / PDF

  187. Oruc MT, Soran A, Jain AB, Wilson JW, Fung J. De novo breast cancer in patients with liver transplantation: University of Pittsburgh’s experience and review of the literature. Liver Transpl. 2004 Jan;10(1):1-6. PubMed / PDF

  188. Bozorgzadeh Adel, Jain, Ashok, Ryan, Charlotte, Ornt, Daniel, Zand, Martin 2 Mantry, Parvez, Lansing, Kerrie, Orloff, Mark impact of hepatitis c viral infection in primary cadaveric liver allograft versus primary living-donor allograft in 100 consecutive liver transplant recipients receiving tacrolimus. Transplantation. 2004 April 15;77(7):1066-1071 PubMed / PDF

  189. Kareem M. Abu-Elmagd, Marsh Zak, June M. Stamos, Geoff J. Bond, AB Jain, Ada O. Youk, Mohamed Ezzelarab, Guilherme Costa, Tong Wu, Michael A. Nalesnik, Anthony J. Demetris, and Jorge D. Reyes. De novo malignancies after intestinal and multivisceral transplantation. Transpl. 2004 June;15 (77): 1719-1725. PubMed / PDF

  190. DiMartini, Dew MA, Javed L, Fitzgerald MG, Jain A, Day N. Pre-transplant psychiatric and medical comorbidity of alcoholic liver disease patients who received liver transplant. Psychosomatics 2004; 45 (6):517 PubMed / PDF

  191. Pan C, Jain A, Fung JJ. Analysis of causes of late mortality in liver transplant recipients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004; 16 (9): 547 PubMed

  192. Jaya Pisupati, AB Jain, Gilbert Burlkart, Imad Hamad, Sheila Zucuerman, John Fung, Raman Venkataramanan. Intra-and inter-individual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients. Journal of Clinical Pharmacology 2005; 45 (1): 34 PubMed / PDF

  193. Ashokkumar Jain, Amadeo Marcos, Reye S, George Mazariegos, Randeep Kashyap, Bijan Eghtesad, Wallis Marsh, Paulo Fontas, Mike De Vera, Guilherme Costa, Kusum Patel, Mary Gadomski, Thomas Starzl, John Fung. Tacrolimus for Primary liver Transplantation: 12 to 15 years actual follow up with safety profile. Transplantation Proceedings 2005; 37(2): 1207-10 PubMed / PDF

  194. Dimartini A, Javed L, Russell S, Dew MA, Fitzgerald MG, Jain A, Fung J. Tobacco use following liver transplantation for alcoholic liver disease: An underestimated problem. Liver Transplantation 2005; Jun; 11(6); 679-83 PubMed / PDF

  195. Ashokkumar Jain, Raman Venkataramanan, Barbara Yelochan, Randeep Kashyap, Amadeo Marcos, John Fung. Ribavirin levels in post Liver transplant (LTx) patients treated for recurrent hepatitis C viral (HCV) infection. Transplantation Proceedings 2005 Sep;37(7):3190-6 PubMed / PDF

  196. Ashokkumar Jain, Mark Orloff, Randeep Kashyap, Kerrie Lansing, Robert Betts, Marilyn Menegus, Charlotte Ryan, Adel Bozorgzadeh. Does Valganciclovir hydrochloride (Valcyte™) provide effective prophylaxis against Cytomegalovirus (CMV) infection in liver transplant recipients? Transplantation Proceedings 2005 Sep;37(7):3182-6 PubMed / PDF

  197. Ashokkumar Jain, Mark Orloff, Peter Abt, Randeep Kashyap, Kerrie Lansing, Joan Romano, Adel Bozorgzadeh. Survival outcome after hepatic retransplantation for Hepatitis C viral positive and negative recipients. Transplantation Proceedings 2005 Sep;37(7):3159-61 PubMed / PDF

  198. Ashokkumar Jain, Mark Orloff, Peter Abt, Randeep Kashyap, Kerrie Lansing, Mark Kelley, Adel Bozorgzadeh. Use of Hepatitis B core antibody positive liver allograft in hepatitis C viral (HCV) positive and HCV negative recipients with use of short course of hepatitis B immunoglobulin (HBIg) and Lamivudine. Transplantation Proceedings 2005 Sep;37(7):3187-9 PubMed / PDF

  199. Ashokkumar Jain, Mark Orloff, Peter Abt, Randeep Kashyap, Kerrie Lansing, Adel Bozorgzadeh. Impact of older donor graft in Liver transplantation with Hepatitis C viral infection. Transplantation Proceedings 2005 Sep;37(7):3162-4 PubMed / PDF

  200. Kelly M, Jain A, Kashyap R, Orloff M, Abt P, Wrobble K, Venkataramanan R, Bozorgzadeh A. Changes in oral absorption of Tacrolimus in post-Liver transplant patients after reversal of Jejunoileal (JI) bypass: case report Transplantation Proceedings 2005 Sep;37(7):3165-7 PubMed / PDF

  201. Ashokkumar Jain, Raman Venkataramanan, Bijan Eghtesad, Mary Gadomski, Ravi Mohanka, Amadeo Marcos, John Fung. Long term outcome of adding Mycophenolate Mofetil (MMF) to tacrolimus for nephrotoxicity following liver transplantation (LTx). Transplantation 2005 Sep 27;80(6):859-864. PubMed / PDF

  202. Shah A, Kendall G, Demme RA, Taylor J, Bozorgzadeh A, Orloff M, Jain A, Abt P, Zand MS. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation. 2005 Sep 27;80(6):775-81 PubMed / PDF

  203. Ashokkumar B. Jain, Amadeo Marcos, Renu Pokharna, Ron Shapiro, Paulo A. Fontes, Wallace Marsh, Ravi Mohanka, and John J. Fung. Rituximab (chimeric anti-CD20 antibody) for post transplant lymphoproliferative disorder (PTLD) after solid organ transplantation in adults: long term experience from a single center. Transplantation 2005 Dec 27;80(12):1692-1698. PubMed / PDF

  204. Ashokkumar Jain, Guilherme Costa, Wallis Marsh, Paulo Fontes, Michael Devera, George Mazariegos, Jorge Reyes, Kusum Patel, Ravi Mohanka, Mary Gadomski, John Fung, Amadeo Marcos. Thrombotic and non-thrombotic hepatic artery complications in adults and children following primary liver transplantation with long term follow-up in 1000 consecutive patients. Transplant International 2006 Jan;19(1):27-37 PubMed / PDF

  205. Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Kelley M, Burlee K, Bozorgzadeh A. Intravenous Mycophenolate Mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation. Exp Clin Transplant 2005 Dec;3(2):361-5. PubMed / PDF

  206. DiMartini A, Day N, Dew MA, Javed L, Fitzgerald MG, Jain A, Fung JJ, Fontes P. Alcohol consumption patterns and predictors of use following liver transplantation from alcoholic liver disease. Liver Transplantation 2006, May;12(5):813-20. PubMed / PDF

  207. Angona R, Abt P, Younan D, Massey T, Marvin M, Kashyap R, Richards D, Jones K, Queschenbach J, Zand M, Jain A, Orloff M, Bozorgzadeh A. Modification of a biventricular assist device to facilitate preservative infusion and organ recovery on a non-heart-beating donor. J Extra Corpor Technol 2006 Jun;38(2):157-60. PubMed / PDF

  208. Jain A, Menegus M, Mohanka R, Orloff M, Abt P, Mantry P, Bozorgzadeh A. HCV antibody quantitative levels in liver transplant patients: do they have any relevance in clinical practice? Exp Clin Transplant 2006 Jun;4(1):475-80. PubMed / PDF

  209. Jain A, Mohanka R, Orloff M, Abt P, Kashyap R, Cullen J, Lansing K, Bozorgzadeh A. University of Wisconsin versus Histidine-Tryptophan-Ketoglutarate for tissue preservation in live donor liver transplantation. Exp Clin Transplant 2006 Jun;4(1):451-7. PubMed / PDF

  210. Jain A, Mohanka R, Orloff M, Abt P, Ryan C, Bozorgzadeh A. Question of using Valganciclovir for cytomegalovirus (CMV) infection prophylaxis in post liver transplant recipients. Liver Transplantation 2006 Jun;12(6):1020-1; author reply 1022-3. PubMed / PDF

  211. Maloo M, Abt P, Kashyap R, Younan D, Zand M, Orloff M, Jain A, Pentland A, Scott G, Bozorgzadeh A. Nephrogenic systemic fibrosis among liver transplant recipients: a single institution experience and topic update. American Journal of Transplantation 2006 Sep;6(9):2212-7. PubMed / PDF

  212. Jain A, Mohanka R, Orloff M, Abt P, Romano J, Bryan L, Batzold P, Mantry P, Bozorgzadeh A. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post liver transplant biopsies. Clinical Transplantation 2006 Sep-Oct;20(5):624-33. PubMed / PDF

  213. Jain A. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection. (Editorial) Liver Transplantation 2006, Oct;12(10):1452-4. PubMed / PDF

  214. de Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, Marcos A, Demetris A, Jain A, Fung JJ, Ragni MV. Survival of liver transplant patients co-infected with HIV and HCV is adversely impacted by recurrent hepatitis C. American Journal of Transplantation 2006; 6: 2983-2993. PubMed / PDF

  215. Abt P, Kashyap R, Orloff M, Jain A, Tsoulfas G, Bozorgzadeh A, Orloff K. Pediatric liver and kidney transplantation with allografts from DCD donors: a review of UNOS data. Transplantation 2006 Dec;82(12):1708-11. PubMed / PDF

  216. Jain A, Orloff M, Abt P, Kashyap R, Mantry P, Bozorgzadeh A. Postoperative impact of intraoperative biochemical changes at the completion pf parenchymal division in living donor liver transplantation. Exp Clin Transplantation 2006 Dec;4(2):544-8. PubMed / PDF

  217. Jain A.; Venkataramanan R.; Kwong T.; Mohanka R.; Orloff M.; Abt P.; Kashyap R.; Tsoulfas G.; Mack C.; Williamson M.; Batzold P.; Bozorgzadeh A. Pharmacokinetics of Mycophenolic Acid in Liver Transplantation Patients After Intravenous and Oral Administration of Mycophenolate Mofetil. Liver Transplantation 13(6):791-796, June 2007 PubMed / PDF

  218. Bozorgzadeh A.; Orloff M.; Abt P.; Tsoulfas G.; Younan D.; Kashyap R.; Jain A.; Mantry P.; Maliakkal B.; Khorana A.; Schwartz S. Survival Outcomes in Liver Transplantation for Hepatocellular Carcinoma, Comparing Impact of Hepatitis C Versus Other Etiology of Cirrhosis. Liver Transplantation 13(6):807-813, June 2007 PubMed / PDF

  219. Patel S, Orloff M, Tsoulfas G, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Living-Donor Liver Transplantation in the United States: Identifying Donors at Risk for Perioperative Complications. American Journal of Transplantation 7(10):2344-2349, October 2007 PubMed / PDF

  220. Nickels M, Jain A, Sharma R, Orloff M, Tsoulfas G, Kashyap R, Bozorgzadeh A. Polysubstance abuse in liver transplant patients and its impact on survival outcome. Exp Clin Transplant 2007 Dec;5(2):680-5. PubMed / PDF

  221. Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. Transplantation 2008; 85(4): 554-60. PubMed / PDF

  222. Patel S, Cassuto J, Orloff M, Tsoulfas G, Zand M, Kashyap R, Jain A, Bozorgzadeh A, Abt P. Minimizing Morbidity of Organ Donation: Analysis of Factors for Perioperative Complications After Living-Donor Nephrectomy in the United States. Transplantation 2008; 85(4): 561-565 PubMed / PDF

  223. Jain A, Sharma R, Ryan C, Tsoulfas G, Orloff M, Abt P, Kashyap R, Batzold P, Sauberman L, Safadjou S, Graham M, Bozorgzadeh A. Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction. Liver Transpl 2008 Feb;14(2):202-9. PubMed / PDF

  224. Jain A, Venkataramanan R, Sharma R, Kwong T, Abt P, Orloff M, Kashyap R, Tsoulfas G, Bozorgzadeh A. Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients. J Clin Pharmacol 2008 May; 48(5): 547-52. PubMed / PDF

  225. Tretheway D, Jain A, LaPoint R, Sharma R, Orloff M, Milot P, Bozorgzadeh A, Ryan C. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score? Liver Transpl 2008 May;14(5):695-700. PubMed / PDF

  226. Kashyap R, Bozorgzadeh A, Abt P, Tsoulfas G, Maloo M, Sharma R, Patel S, Dombroski D, Mantry P, Safadjou S, Jain A, Orloff M. Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography. Transplantation 2008 Jun 15; 85(11):1569-72. PubMed / PDF

  227. Jain A, Patil VP, Horton P, Patel N, Kashyap R, Tsoulfas G, Orloff M, Bozorgzadeh A. Common iliac artery lying posterior to psoas major identified during kidney transplantation. Transplantation 2008 Aug 27; 86(4):623-4. PubMed / PDF

  228. Jain A, Patil VP, Fung J. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl 2008 Oct; 14(10):1406-11 PubMed / PDF

  229. Choi DX, Jain AB, Orloff MS. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients. J Am Coll Surg 2009 Apr; 208(4):539-46. PubMed / PDF

  230. Kashyap R, Mantry P, Sharma R, Maloo MK, Safadjou S, Qi Y, Jain A, Maliakkal B, Ryan C, Orloff M. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg 2009 Aug;13(8):1480-6. PubMed / PDF

  231. Jain A, Fiaz O, Sheikh B, Sharma R, Safadjou S, Kashyap R, Bryan L, Batzold P, Orloff M. Recurrent nonhepatic and de novo malignancies after liver transplantation. Transplantation. 2009 Sep 15; 88(5):706-10. PubMed / PDF

  232. Kashyap R, Ryan C, Sharma R, Maloo MK, Safadjou S, Graham M, Tretheway D, Jain A, Orloff M. Liver grafts from donors with central nervous system tumors: a single-center perspective. Liver Transpl. 2009 Oct;15(10):1204-8. PubMed / PDF

  233. Jain A, Nemitz P, Sharma R, Sheikh B, Safadjou S, Vetter M, Brayan L, Batzold P, Kashyap R, Orloff M. Incidence of abdominal wall numbness post-liver transplantation and its complications. Liver Transpl 2009 Nov;15(11):1488-92. PubMed / PDF

  234. Jain A, Sharma R, Ryan C, Safadjou S, Kashyap R, Mantry P, Maliakkal B, Orloff M. Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience. Clin Transplant 2010 Jan-Feb; 24(1):104-11. PubMed / PDF

  235. Sharma R, Kashyap R, Jain A, Safadjou S, Graham M, Dwivedi AK, Orloff M. Surgical complications following liver transplantation in patients with portal vein thrombosis–a single-center perspective. J Gastrointest Surg 2010 Mar;14(3):520-7. PubMed / PDF

  236. Jain AB, Patil V, Sheikh B, Apostolakos M, Ryan C, Kashyap R, Orloff M. Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases. Exp Clin Transplant 2010;8(1):4-8. PubMed / PDF

  237. Karachristos A, Herrera A, Sifontis NM, Darrah J, Baribault C, Lee I, Leech SH, Constantinescu S, Gaughan J, Jain A, Silva P, Daller JA. Outcomes of renal transplantation in older high risk recipients: is there an age effect? J Surg Res. 2010 Jun 15;161(2):173-8. PubMed / PDF

  238. Zand MS, Orloff MS, Abt P, Patel S, Tsoulfas G, Kashyap R, Jain A, Safadjou S, Bozorgzadeh A. High mortality in orthotopic liver transplant recipients who require hemodialysis. Clin Transplant 2010 Mar 19. PubMed / PDF

  239. Singhal A, Jain AB, Burke M, Black M. Aggressive use of ribavirin and prolonged course of peginterferon to improve the rate of viral response in liver transplant patients with recurrent hepatitis C viral infection. Exp Clin Transplant 2010; 8(3): 214-9 PubMed / PDF

  240. Kuypers DRJ, Le Meur Y, Cantarovich M, Tredger MJ, Tett SE, Cattaneo D, et al. Consensus Report on Therapeutic Drug Monitoring of Mycophenolic Acid in Solid Organ Transplantation. Clin J Am Soc Nephrol 2010; 5: 341-358 PubMed

  241. Ashokkumar Jain, Ashish Singhal, Paulo Fontes, George Mazariegos, Michael E. deVera, Thomas Cacciarelli, Roberto C. Lopez, Rakesh Sindhi, Abhi Humar, J. Wallis Marsh. One Thousand Consecutive Primary Liver Transplants under Tacrolimus Immunosuppression: A 17- to 20-Year Longitudinal Follow-Up. Transplantation 2011; 91 (9): 1025-1030. PubMed / PDF

  242. Jacqueline M. von Vital, Andreas Karachristos, Ashish Singhal, Rebecca Thomas, Ashokkumar Jain. Acute Amiodarone Hepatotoxicity following Liver Transplantation. Transplantation 2011; 91 (8): e62-e64. PubMed / PDF

  243. Ashokkumar Jain, Ashish Singhal, Randeep Kashyap, Saman Safadjou, Charlotte K. Ryan, Mark S. Orloff. Comparative Analysis of Hepatitis C Recurrence and Fibrosis Progression between Deceased Donor and Living Donor Liver Transplantation: 8-year Longitudinal Follow-Up. Transplantation. 2011; 92(4):453-60. PubMed / PDF

  244. Cantarovich M, Brown NW, Ensom MH, Jain A, Kuypers DR, Van Gelder T, Tredger JM. Mycophenolate monitoring in liver, thoracic, pancreas, and small bowel transplantation: a consensus report. Transplant Rev (Orlando). 2011; 25(2): 65-77. PubMed / PDF

  245. Ashish Singhal, Andreas Karachristos, Michael Bromberg, Ellen Daly, Manoj Maloo, Ashokkumar Jain. Hypercoagulability in patients with End Stage Liver Disease: Prevalence and correlation with Severity of Liver Disease and Portal Vein Thrombosis. Accepted in Clinical Applied Thrombosis Hemostasis. 2012 Apr 11. [Epub ahead of print] PDF

  246. Ashish Singhal, Elaine Lander, Andreas Karachristos, Ellen Daly, Phyllis Dowling, Manoj Maloo, Vishal Patel, Ashokkumar Jain. Elevation of CA 125 and CA 19-9 in Patients with End Stage Liver Disease. Clin Appl Thromb Hemost. 2012 Nov;18(6):594-8 / PDF

  247. Smit Singla, Anne Warner, Ashokkumar Jain, Rebecca M Thomas, Andreas Karakristos. Oriental cholangiohepatitis masquerading as cholangiocarcinoma: A rare presentation surgeons need to know. Accepted in International Journal of Surgery Case Reports. 2012; 3(7):235-7. PubMed / PDF

  248. Amar N Mukerji, Vishal Pat el, Ashokkumar Jain. Improving Survival in Decompensated Cirrhosis. Int J Hepatol. Volume 2012, Article ID 318627, 14 pages doi:10.1155/2012/318627 PubMed / PDF

  249. Amar N Mukerji, Esther Tseng, Andreas Karachristos, Manoj Maloo, Ashokkumar Jain. Chylous Ascites after Liver Transplantation: Case Report and Review of Literature. Accepted in Experimental and Clinical Transplantation. 9-18-2012 [Manuscript# ECT-OA-08-12-0203] PDF

  250. Ashish Singhal, Andreas Karachristos, Amar Mukerji, Athanasios Thomaides, Manoj Maloo, Benjamin Sanchez, Michael Keresztury, Thomas A. Santora, Ashokkumar Jain. Chronotropic Incompetence on Dobutamine Stress Echocardiography in Candidates for Liver Transplantation. Experimental and Clinical Transplantation (2013) 6: 546-553 PDF

  251. Amar Nath Mukerji, Andreas Karachristos,Manoj Maloo, David Johnson,and Ashokkumar Jain, Do Post liver Transplant Patients Need Thromboprophylactic Anticoagul ation? Clinical and Applied Thrombosis/Hemostasis.2014, Vol. 20(7) 673-677,ª The Author(s) 201 PDF

  252. Ashokkumar Jain,Serban Constantinescu,Manoj Maloo,Amar Nath Mukerji.Andreas Karachristos,Kwan Lau,Antonio Di Carlo.Delayed Introduction of Tacrolimus Postliver Transplant With Intravenous Mycophenolate Mofetil Preserves Renal Function Without Incurring Rejection E68-70 Transplantation Transplantation & Volume 98, Number 7, p e68-70. October 15, 2014 PDF

  253. Kadry, Z.Schaefer, E. W.Shah, R. A.Krok, K.Du, P.Bezinover, D.Janicki, P.Jain, A.Gusani, N. J.Schreibman, I. R.Hollenbeak, C. S.Riley, T. R., 3rd.Portal Hypertension: An Underestimated Entity? Ann. Surg. 2015;001-6 PDF

  254. Dennis F. Habig; Justine L. Gaspari; Parvez M. Lokhandwala; Ronald E. Domen; Catherine S. AbDonor-specific antibody to trans-encoded donor HLA-DQ heterodimer Human Immunology, 76 (2015) 587-590. doi:10.1016/j.humimm.2015.09.004 PDF